These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 15322598

  • 21. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
    Song HM, Zhang J, Deng B, Luo M.
    Zhonghua Yi Xue Za Zhi; 2005 Jul 06; 85(25):1737-40. PubMed ID: 16253158
    [Abstract] [Full Text] [Related]

  • 22. Decompensated heart failure in the setting of kidney dysfunction: a community-wide perspective.
    Ismailov RM, Goldberg RJ, Lessard D, Spencer FA.
    Nephron Clin Pract; 2007 Jul 06; 107(4):c147-55. PubMed ID: 17957126
    [Abstract] [Full Text] [Related]

  • 23. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I, Rubonivich S, Azaz-Livshits T.
    Isr Med Assoc J; 2008 Mar 06; 10(3):214-8. PubMed ID: 18494235
    [Abstract] [Full Text] [Related]

  • 24. Serum and urinary magnesium during treatment of patients with chronic congestive heart failure.
    Oladapo OO, Falase AO.
    Afr J Med Med Sci; 2000 Mar 06; 29(3-4):301-3. PubMed ID: 11714011
    [Abstract] [Full Text] [Related]

  • 25. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker adherence in patients with primary versus secondary diagnosis of heart failure.
    Brackbill ML, Bashaw-Keaton R, Sytsma CS.
    Am J Manag Care; 2007 Oct 06; 13(10):568-70. PubMed ID: 17927461
    [Abstract] [Full Text] [Related]

  • 26. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S, Warfield KT, Wood CM, Miller WL.
    Am J Cardiol; 2006 Dec 15; 98(12):1627-30. PubMed ID: 17145223
    [Abstract] [Full Text] [Related]

  • 27. [Improvement of short-term prognosis in patients with refractory heart failure].
    Boffa GM, Cannas S, Cacciavillani L, Marzari A, Grassi G, Bauce B, Livi U, Maddalena F.
    G Ital Cardiol; 1997 Oct 15; 27(10):1024-8. PubMed ID: 9410772
    [Abstract] [Full Text] [Related]

  • 28. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein A, Andrade SE, Lafata JE, Roblin D, Davis RL, Gunter MJ, Platt R.
    Pharmacoepidemiol Drug Saf; 2007 Jan 15; 16(1):55-64. PubMed ID: 16470693
    [Abstract] [Full Text] [Related]

  • 29. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
    Fauchier L, Grimard C, Pierre B, Nonin E, Gorin L, Rauzy B, Cosnay P, Babuty D, Charbonnier B.
    Am J Cardiol; 2009 Jan 15; 103(2):248-54. PubMed ID: 19121446
    [Abstract] [Full Text] [Related]

  • 30. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG.
    J Indian Med Assoc; 2009 Mar 15; 107(3):178-82. PubMed ID: 19810392
    [Abstract] [Full Text] [Related]

  • 31. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M, Greenberg BH, Yancy CW, Young JB, Fonarow GC.
    Am Heart J; 2008 Oct 15; 156(4):662-73. PubMed ID: 18926148
    [Abstract] [Full Text] [Related]

  • 32. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
    Qureshi IZ, Abid K, Ambreen F, Qureshi AL.
    Saudi Med J; 2007 Feb 15; 28(2):193-6. PubMed ID: 17268695
    [Abstract] [Full Text] [Related]

  • 33. Patient differences related to management in general practice and the hospital: a cross-sectional study of heart failure in the community.
    Nielsen OW, McDonagh T, Cowburn P, Blue L, Robb SD, Dargie H.
    Eur Heart J; 2004 Oct 15; 25(19):1718-25. PubMed ID: 15451150
    [Abstract] [Full Text] [Related]

  • 34. Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction.
    Di Pasquale P, Cannizzaro S, Scalzo S, Parrinello G, Fasullo S, Giambanco F, Fatta A, Paterna S.
    Am Heart J; 2005 Nov 15; 150(5):919. PubMed ID: 16290961
    [Abstract] [Full Text] [Related]

  • 35. [Electrolyte abnormalities and metabolic acidosis in two Duchenne muscular dystrophy patients with advanced congestive heart failure].
    Matsumura T, Saito T, Miyai I, Nozaki S, Kang J.
    Rinsho Shinkeigaku; 2000 May 15; 40(5):439-45. PubMed ID: 11002725
    [Abstract] [Full Text] [Related]

  • 36. Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
    Gradman AH, Papademetriou V.
    Am Heart J; 2009 Jun 15; 157(6 Suppl):S17-23. PubMed ID: 19450720
    [Abstract] [Full Text] [Related]

  • 37. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
    Azadpour M, Lamas GA.
    Expert Rev Cardiovasc Ther; 2004 Nov 15; 2(6):891-902. PubMed ID: 15500434
    [Abstract] [Full Text] [Related]

  • 38. Use of digitalis in the treatment of heart failure: data from the Italian Network on Congestive Heart Failure (IN-CHF).
    Camerini A, Griffo R, Fabbri G, Aspromonte N, Ingrillì F, Lucci D, Naccarella F, Maggioni AP, IN-CHF Investigators.
    Ital Heart J; 2004 Jul 15; 5(7):523-9. PubMed ID: 15487270
    [Abstract] [Full Text] [Related]

  • 39. Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failure.
    Hess G, Preblick R, Hill J, Plauschinat CA, Yaskin J.
    Congest Heart Fail; 2009 Jul 15; 15(4):170-5. PubMed ID: 19627290
    [Abstract] [Full Text] [Related]

  • 40. Comparison of target concentration intervention strategy with conventional dosing of digoxin.
    Rajendran SD, Rao YM, Thanikachalam S, Muralidharan TR, Anbalagan M.
    Indian Heart J; 2005 Jul 15; 57(3):265-7. PubMed ID: 16196188
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.